News and Updates


The Gold Standard for Current Cancer Treatment

Klepper's perspective:

"Elaine and I talked about this. Given the chance to do it over, would she have gone through 3 lines of “gold standard” chemotherapy again, with their profound impacts and the remote chances of success? The tradeoffs between hope and quality of life were simply too great. Her answer was an unequivocal no."

Read more here as Dr. Klepper discusses his perspective on what has been touted as the "gold standard" regarding cancer treatments.


Too Many Advanced Cancer Patients Lack Basic Understanding About Their Disease

Only 5% of Terminally Ill Advanced Cancer Patients Fully Understood Prognosis

Only a small consortium of advanced cancer patients were able to show that they could identify and fully understand their prognosis according to a study led by faculty members from Memorial Sloan Kettering and Weill Cornell Medicine, which aimed to uncover the influence of prognostic discussions on the accuracy of illness understanding.

The open access study, published in the Journal of Clinical Oncology,... Read More

Mentee Jason Lambden MSTAR Program Acceptance

Jason Lambden M.D. Candidate | Class of 2019

"Physician and Registered Nurse Moral and Psychological Distress in Treatment of Terminally Ill Patients"

On behalf of faculty and staff here at Weill Cornell's Center for Research on End-of-Life Care, we would like to congratulate first year medical student Jason Lambden on his acceptance into the 2016 Medical Student Training in Aging Research (MSTAR) Program.

There has been increasing evidence that... Read More

Weill Cornell Medicine Center for Research on End-of-Life Care 525 E 68th St, Box 39,
1414 Baker Pavilion
New York, NY 10065